Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing's syndrome - S Noe, H Jaeger, S Heldwein, 2018
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
Ritonavir - Wikipedia
HIV-Protease Inhibitors: Viral Resistance, Pharmacokinetic Boosting, and Medication Adherence
Solved A study for the treatment of patients with HIV-1 was | Chegg.com
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study - The Lancet HIV
How Ritonavir acts as booster drug - YouTube
Summary of unboosted and ritonavir-boosted PI dose regimens | Download Table
Ritonavir (Norvir)
Improvement in Bioavailability and Pharmacokinetic Characteristics of Efavirenz with Booster Dose of Ritonavir in PEGylated PAMAM G4 Dendrimers | SpringerLink
Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression - ScienceDirect
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens | PLOS ONE
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Ritonavir | C37H48N6O5S2 | CID 392622 - PubChem
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial - The Lancet HIV
Boosted protease inhibitor and lamivudine provides effective maintenance treatment | aidsmap
Ritonavir 155213-67-5 | TCI AMERICA
How Ritonavir acts as booster drug - YouTube
Ritonavir (Norvir) - Indications, Dose, Side effects
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment | Scientific Reports
Trial profile. DTG, dolutegravir; PI/r, ritonavir-boosted protease... | Download Scientific Diagram
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
